This text is a result of machine translation.
Zelensky called on the international community to provide funds for Ukraine's reconstruction, which is expected to cost $500 billion
China's First Oral COVID-19 Antiviral Medicine in Dispute
An obscure Chinese company called Genuine Biotech(Chinese: 真实生物) was suddenly put under the spotlight on July 25 when the Chinese authority announced the conditional approval of the company's application for adding the treatment of COVID-19 as a new indication of Azvudine under the special review and approval procedures for drug registration.
Aug 08, 2022 09:00 AM
913 companies have been investigated by public funds since the second quarter, and the six top flow fund managers focus on the leaders of subdivided industries
The Overlooked 120 Million Consumers
Japan is a demanding but high-value market. Chinese sellers are growing fast, yet success requires more than low prices—clear manuals, strong quality, 24/7 service, and trust. Consumption is polarizing, and aging buyers remain active. Long-term branding and localization are key.
Oct 29, 2025 05:24 PM
EqualOcean Weekly Hotspots Series (8/17-8/22)
Amid fast-paced changes that fill the business community with excitement, angst and trepidation, EqualOcean will publish a series of roundup articles to document the major events related to Chinese companies going global every week.
Aug 22, 2025 11:25 AM
A number of enterprises on the science and innovation board are listed on the "white list" of key enterprises for operation guarantee and transfer
Meituan's Food Delivery Brand Keeta Launches in Qatar, Plans to Enter Brazil in Months
On August 19 (local time in Qatar), Keeta, the international food delivery brand under Chinese tech and retail giant Meituan, officially launched in Doha, the capital of Qatar. This marks another layout of Keeta in the Middle East market following its entry into Saudi Arabia.
Aug 20, 2025 06:44 PM
Junshi Biosciences Receives NMPA Approval of sNDA for Toripalimab
The study data showed that compared to chemotherapy alone, toripalimab in combination with chemotherapy in the first-line treatment of patients with advanced NSCLC without EGFR/ALK mutations could significantly improve the PFS and the OS of patients with a manageable safety profile regardless of PD-L1 expression status.
Sep 20, 2022 03:35 PM
Fengtai District of Beijing will lift the epidemic prevention zone of the whole region from now on.